About Moderna, Inc.
Moderna, Inc. (MRNA) has been publicly traded since 2018, making it a 8-year-old public company. It operates in the Biotechnology industry within the Healthcare sector. The company is headquartered in Cambridge, United States and employs approximately 4,700 people. With a market capitalization of $21 billion, MRNA is a large established company.
Key Statistics
- Current Price
- $52.37
- Market Cap
- $20.68B
- 52-Week High
- $59.55
- 52-Week Low
- $22.28
- Sector
- Healthcare
- Industry
- Biotechnology
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +77.59% | $29.49 | $52.37 |
| 2025 | -29.08% | $41.58 | $29.49 |
| 2024 | -58.19% | $99.45 | $41.58 |
| 2023 | -44.63% | $179.62 | $99.45 |
| 2022 | -29.28% | $253.98 | $179.62 |
| 2021 | +143.11% | $104.47 | $253.98 |
| 2020 | +434.10% | $19.56 | $104.47 |
| 2019 | +28.09% | $15.27 | $19.56 |
Valuation
The forward P/E ratio is -11.5. The price-to-book ratio stands at 2.4. The price-to-sales ratio is 10.7.
Dividends
Moderna, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
MRNA has a beta of 1.35, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $22.28 to $59.55, and it currently trades near its 52-week high.
Analyst Ratings
Based on 20 analyst opinions, MRNA has a consensus "hold" rating. The average price target of $42.90 suggests 18.4% downside from current levels.
Frequently Asked Questions
What does Moderna, Inc. do? ▼
Moderna, Inc. is a Biotechnology company operating in the Healthcare sector. The company is headquartered in Cambridge, United States.
What sector is MRNA in? ▼
MRNA operates in the Healthcare sector, specifically in the Biotechnology industry.
When did MRNA go public? ▼
Moderna, Inc. went public in 2018, making it a 8-year-old public company as of 2026.
How much would $1,000 invested in MRNA 5 years ago be worth today? ▼
A $1,000 investment in MRNA five years ago would be worth approximately $400 today, representing a -60.0% return.
Does MRNA pay dividends? ▼
No, Moderna, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is MRNA's market cap? ▼
Moderna, Inc. has a market capitalization of $21 billion, classifying it as a large-cap company.
Is MRNA a buy, hold, or sell? ▼
Based on 20 opinions, MRNA has a consensus "hold" rating. The average price target is $42.9.
Last updated: 3/14/2026